Pharma Digest

Regulatory Guidelines for CSV

Regulatory Guidelines for CSV

Embarking on the path to a successful Computer System Validation (CSV) roadmap begins with a solid understanding of the applicable regulatory requirements within your industry and region. Investing the time to understand which regulations you must comply with, which are advantageous, and which, are the gold standard, is a crucial ... Read More
Inadequate Investigations: A Common Observation by the FDA

Inadequate Investigations: A Common Observation by the FDA

During cGMP inspections, one of the most commonly cited observations by the FDA is the inadequate investigation into deviations. Pharmaceutical companies must address this issue to maintain compliance and ensure patient safety. Here are some key points to keep in mind regarding deviation investigations in the pharmaceutical industry: Observation Highlight ... Read More
Quality by Design (QbD) in Pharmaceutical Development

Quality by Design (QbD) in Pharmaceutical Development

Quality by design (QbD) is a scientific and risk-based approach to pharmaceutical product development that begins with predefined objectives. Instead of relying on finished product testing alone, QbD ensure the product quality throughout the development process. Objective of QbD Approach Elements of QbD QbD comprises different elements of pharmaceutical development ... Read More
Basic Guideline for Prometric Examination (UAE)

Basic Guideline for Prometric Examination (UAE)

Prometric exam is a world’s most recognized licensing and certification organization. In this article we discuss on the medical professional licensing way in UAE throgh prometic examination. There are 3 types of license available in UAE for medical professional: 1. The Ministry of Health, UAE (MOH)  2. Dubai Health Authority ... Read More
Validation and Qualification In Pharmaceutical Manufacturing

Validation and Qualification In Pharmaceutical Manufacturing

What is Validation? As per EU GMP – It is “Action of proving, in accordance with the principles of Good Manufacturing Practice (GMP), that any procedure, process, equipment, material, activity or system actually leads to expected results. What is Qualification? Comparison between Qualification and Validation Why Validation? What to Qualify/Validate? ... Read More
GMP in Pharmaceutical Industry

GMP in Pharmaceutical Industry

GMP stands for Good Manufacturing Practices. It is a set of guidelines and regulations to ensure that pharmaceutical products are consistently produced and controlled to the quality standards appropriate for their intended use. This includes guidelines for the design, monitoring, and control of manufacturing processes, as well as quality control ... Read More
Patents and Exclusivity in Pharmaceutical Industry

Patents and Exclusivity in Pharmaceutical Industry

Did you know that “patent” and “exclusivity” are two of the most commonly searched terms on the FDA website? Generics account for more than 80% of prescription drugs in the US, and that number continues to grow. With approaching patent expirations of several top selling prescription brand-name drugs, sponsors of ... Read More
Walking Through the 21 CFR Part 11

Walking Through the 21 CFR Part 11

FDA

If you are connected to the life sciences industry in one way or another, you have undoubtedly heard of the United States Food and Drug Administration’s (FDA’s) 21 Part 11 Regulation. We begin by decoding 21 CFR Part 11 itself: The CFR is organized like this: Title > Chapter > ... Read More
Vendor Audit in Pharmaceutical Industry

Vendor Audit in Pharmaceutical Industry

Vendor audit is an evaluation of a vendor manufacturing process, practices, documentations and quality compliance by offline (physical) or online (desktop). Conducting a vendor audit in the pharmaceutical industry is an essential process to ensure that suppliers and vendors meet the required standards and regulations. Vendor Audit Process Define Audit ... Read More
APIC Guidance on the Risk Assessment for Presence of N-Nitrosamines in APIs

APIC Guidance on the Risk Assessment for Presence of N-Nitrosamines in APIs

The EMA and other Health authorities have published requirements (EMA/189634/2019) and Health Canada Letter for the API industry and the MAH for drug products to expand the scope of potential sources of nitrosamines beyond that of ICH M7. This requirement is based on the fact that, as the Industry and ... Read More
Drug Master File (DMF) in Pharmaceutical Industry

Drug Master File (DMF) in Pharmaceutical Industry

Drug Master File (DMF) is a package of confidential, proprietary assets, specifying the formula, processes, materials, test methods, and other information relevant to the manufacture of product used in the composition, packaging, and/or processing of pharmaceuticals and/or biologics. Types of DMFs Type I: Manufacturing Site, Facilities, Operating Procedures, and Personnel ... Read More